A blood-based test demonstrated acceptable accuracy for colorectal cancer detection in an average-risk colorectal cancer screening population. #ASCO25 ja.ma/3HfAXHJ

Options are emerging for the tens of millions of people who stop taking GLP-1 drugs because of side effects, cost or availability. go.nature.com/4kCqG7f

Presented at #ENDO2025: In 15 patients with primary aldosteronism, baxdrostat (a second-generation, nonimidazole aldosterone synthase inhibitor) resolved or reduced the severity of hypertension, excessive aldosterone production, and hypokalemia. Full SPARK study results:

"In prediabetes, recovery of β-cell function—not just reduced insulin resistance—is key to remission" The Lancet Diabetes & Endocrinology Dr.V.Mohan Dr Ambrish Mithal Daniel J Drucker Scott Isaacs Dr. Shashank Joshi Dr. Anuj Maheshwari Partha S Kar 🇮🇳🇬🇧🏏🎥 Endocrine Connections Young Diabetologists and Endocrinologists’ Forum Dr.S.Ramkumar MD DM (AIIMS) DrNB Dr. Ashok Jhingan, MD ( Diabetologist )

Orforglipron, daily oral GLP-1 pill, shows major promise in lowering blood sugar and weight in type 2 diabetes.

#Nike co-founder Phil Knight and his wife, Penny, will donate $2 billion to Oregon Health & Science University (OHSU) to expand cancer research and patient care. healthday.com/health-news/ca…

On Friday, the FDA granted accelerated approval to Novo Nordisk’s Wegovy for the treatment of metabolic-associated steatohepatitis (MASH) in adults with moderate-to-advanced fibrosis but without cirrhosis. The once-weekly 2.4 mg semaglutide subcutaneous injection is given in

Health Canada approves Ozempic to reduce kidney deterioration in people with diabetes ctvnews.ca/health/article…

First-in-Human Clinical Feasibility Study of Ablation of Benign Thyroid Nodules Using Nanosecond Pulsed Field Ablation | Thyroid® ⁦Iram Hussain⁩ ⁦Unnikrishnan AG⁩ ⁦Dr. Om Lakhani, MD, DNB (ENDO)⁩ ⁦🇮🇳 Dr Sunil Kumar Kota⁩ ⁦Malini Gupta, MD, FACE, ECNU⁩ ⁦Dr.Shinjan Patra DM Endocrinology⁩ liebertpub.com/doi/abs/10.117…

Renoprotected individuals with long-duration type 1 diabetes and good cardiometabolic management can still have significant atherosclerosis, driven mostly by #hyperglycaemia and inflammation #DiabetesResearch #T1D link.springer.com/article/10.100… 🔓

#NEWS Teva announces FDA approval and launch of the first generic GLP-1 in the U.S. specifically indicated to treat weight loss in certain adults and children. This provides an important & in demand treatment option for patients, reinforcing Teva as a generics powerhouse and

In the STEER study, there were 15 (0.1%) cardiovascular events recorded with Wegovy®, and 39 events (0.4%) were recorded with tirzepatide. The average follow-up duration was 3.8 months for the Wegovy® group and 4.3 months for the tirzepatide group. #ESC2025 #CVD #Heartdisease

#Duavee, a medication for #menopause symptoms, shows promise in reducing the risk of invasive breast cancer in postmenopausal women.

#obesity Kushner RF, Almandoz JP, Rubino DM. Managing Adverse Effects of Incretin-Based Medications for Obesity. JAMA. 2025;334(9):822–823. doi:10.1001/jama.2025.11153 #obesity #semaglutide #mounjaro #ozempic #wegovy #tirzepatide

Individuals with #ADHD treated with stimulants have a nonnegligible risk of developing psychosis or bipolar disorder, with a higher risk associated with amphetamines compared to methylphenidate. ja.ma/4gbmZUI

FDA just approved 1st generic GLP-1 for weight loss: Liraglutide, previously generic only in diabetes dose: fda.gov/news-events/pr… How to use it: thecarlatreport.com/articles/5394-… PRO: More trials with antipsychotics than other GLP-1 agonists CON: Branded ones cut more pounds

Kinesiologist/Med student Simran Sandhu discussing exercise prescription in clinic today 👍 #stepcount #exercise

The new #LancetCommission obesity definitions show dramatic differences in risk: 🏈 Athlete, BMI 32—WHO called it class I obesity; now “no obesity” 👵 Older woman, BMI 27+diabetes—WHO overweight; now stage 2 clinical obesity 👩 Woman, BMI 33+prediabetes—WHO class I; now stage 1

Type 2 #diabetes #subtypes classification: a global reckoning with #heterogeneity thelancet.com/journals/landi… #T2D #FREE to read with registration (also FREE) #EASD2025

Artificial intelligence for #diabetes care: current and future prospects thelancet.com/journals/landi… #ArtificialIntelligence #AI #T1D #T2D #EASD2025